{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:40:45Z","timestamp":1791348045994,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer cachexia (CC) is a debilitating syndrome severely impacting patients\u2019 quality of life and survivorship. We aimed to investigate the health care professionals\u2019 (HCPs\u2019) experiences of dealing with CC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Survey questions entailed definitions and guidelines, importance of CC management, clinician confidence and involvement, screening and assessment, interventions, psychosocial and food aspects. The online survey was disseminated through Australian and New Zealand palliative care, oncology, allied health and nursing organisations. Frequencies were reported using descriptive statistics accounting for response rates. Associations were examined between variables using Fisher\u2019s exact and Pearson\u2019s chi-square tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over 90% of the respondents (<jats:italic>n<\/jats:italic>\u2009=\u2009192) were medical doctors or nurses. Over 85% of the respondents were not aware of any guidelines, with 83% considering\u2009\u2265\u200910% weight loss from baseline indicative of CC. CC management was considered important by 77% of HCPs, and 55% indicated that it was part of their clinical role to assess and treat CC. In contrast, 56% of respondents were not confident about managing CC, and 93% believed formal training in CC would benefit their clinical practice. Although formal screening tools were generally not used (79%), 75% of respondents asked patients about specific symptoms. Antiemetics (80%) and nutritional counselling (86%) were most prescribed or recommended interventions, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study underlines the deficiencies in knowledge and training of CC which has implications for patients\u2019 function, well-being and survival. HCP training and a structured approach to CC management is advocated for optimal and continued patient care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10147-023-02300-6","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:03:11Z","timestamp":1677135791000},"page":"592-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Health care professionals\u2019 experiences of dealing with cancer cachexia"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-3712","authenticated-orcid":false,"given":"Jodie","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Ingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-5149","authenticated-orcid":false,"given":"Peter","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3879-2448","authenticated-orcid":false,"given":"Vanessa","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-1250","authenticated-orcid":false,"given":"David C.","family":"Currow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-0910","authenticated-orcid":false,"given":"Valentina","family":"Razmovski-Naumovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"issue":"3","key":"2300_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/0973-029X.86670","volume":"15","author":"R Dhanapal","year":"2011","unstructured":"Dhanapal R, Saraswathi TR, Govind RN (2011) Cancer cachexia. J Oral Maxillofac Pathol 15(3):257\u2013260. https:\/\/doi.org\/10.4103\/0973-029X.86670","journal-title":"J Oral Maxillofac Pathol"},{"issue":"5","key":"2300_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"key":"2300_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1191\/0269216302pm593oa","volume":"16","author":"K Poole","year":"2002","unstructured":"Poole K, Froggatt K (2002) Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional? Palliat Med 16:499\u2013506. https:\/\/doi.org\/10.1191\/0269216302pm593oa","journal-title":"Palliat Med"},{"issue":"1","key":"2300_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcsm.12402","volume":"10","author":"MS Anker","year":"2019","unstructured":"Anker MS, Holcomb R, Muscaritoli M et al (2019) Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle 10(1):22\u201334. https:\/\/doi.org\/10.1002\/jcsm.12402","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"2300_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","volume":"67","author":"L Sun","year":"2015","unstructured":"Sun L, Quan X-Q, Yu S (2015) An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status. Nutr Cancer 67(7):1056\u20131062. https:\/\/doi.org\/10.1080\/01635581.2015.1073753","journal-title":"Nutr Cancer"},{"issue":"Suppl 1","key":"2300_CR6","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1038\/sj.bjc.6601092","volume":"89","author":"P Bachmann","year":"2003","unstructured":"Bachmann P, Marti-Massoud C, Blanc-Vincent MP et al (2003) Summary version of the standards, options and recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer 89(Suppl 1):S107\u2013S110. https:\/\/doi.org\/10.1038\/sj.bjc.6601092","journal-title":"Br J Cancer"},{"key":"2300_CR7","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/annonc\/mdu085","volume":"25","author":"M Aapro","year":"2014","unstructured":"Aapro M, Arends J, Bozzetti F et al (2014) Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol 25:1492\u20131499. https:\/\/doi.org\/10.1093\/annonc\/mdu085","journal-title":"Ann Oncol"},{"issue":"2","key":"2300_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jcsm.12267","volume":"9","author":"LE Daly","year":"2018","unstructured":"Daly LE, Ni Bhuachalla EB, Power DG et al (2018) Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. J Cachexia Sarcopenia Muscle 9(2):315\u2013325. https:\/\/doi.org\/10.1002\/jcsm.12267","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"2300_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jcsm.12391","volume":"10","author":"IMG da Rocha","year":"2019","unstructured":"da Rocha IMG, Marcadenti A, Medeiros GOC et al (2019) Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study. J Cachexia Sarcopenia Muscle 10(2):445\u2013454. https:\/\/doi.org\/10.1002\/jcsm.12391","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2300_CR10","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s11136-019-02135-7","volume":"28","author":"HL Gelhorn","year":"2019","unstructured":"Gelhorn HL, Gries KS, Speck RM et al (2019) Comprehensive validation of the functional assessment of anorexia\/cachexia therapy (FAACT) anorexia\/cachexia subscale (A\/CS) in lung cancer patients with involuntary weight loss. Qual Life Res 28:1641\u20131653. https:\/\/doi.org\/10.1007\/s11136-019-02135-7","journal-title":"Qual Life Res"},{"issue":"1","key":"2300_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpainsymman.2012.06.020","volume":"46","author":"R Oberholzer","year":"2013","unstructured":"Oberholzer R, Hopkinson J, Baumann K et al (2013) Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis. J Pain Symptom Manage 46(1):77\u201395. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.06.020","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"2300_CR12","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00520-017-4022-z","volume":"26","author":"OM Vagnildhaug","year":"2018","unstructured":"Vagnildhaug OM, Balstad TR, Almberg SS et al (2018) A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer. Support Care Cancer 26(6):1871\u20131880. https:\/\/doi.org\/10.1007\/s00520-017-4022-z","journal-title":"Support Care Cancer"},{"key":"2300_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw420","author":"M Muscaritoli","year":"2016","unstructured":"Muscaritoli M, Rossi Fanelli F, Molfino A (2016) Perspectives of health care professionals on cancer cachexia: results from three global surveys. Ann Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdw420","journal-title":"Ann Oncol"},{"issue":"28","key":"2300_CR14","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.3748\/wjg.v20.i28.9361","volume":"20","author":"TC Mueller","year":"2014","unstructured":"Mueller TC, Burmeister MC, Bachmann J et al (2014) Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol 20(28):9361\u20139373. https:\/\/doi.org\/10.3748\/wjg.v20.i28.9361","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2300_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12904-016-0171-y","volume":"15","author":"D Scott","year":"2016","unstructured":"Scott D, Reid J, Hudson P et al (2016) Health care professionals\u2019 experience, understanding and perception of need of advanced cancer patients with cachexia and their families: the benefits of a dedicated clinic. BMC Palliat Care 15(1):1\u20136. https:\/\/doi.org\/10.1186\/s12904-016-0171-y","journal-title":"BMC Palliat Care"},{"issue":"6","key":"2300_CR16","doi-asserted-by":"publisher","first-page":"E393","DOI":"10.1188\/13.ONF.E393-E402","volume":"40","author":"C Millar","year":"2013","unstructured":"Millar C, Reid J, Porter S (2013) Healthcare professionals\u2019 response to cachexia in advanced cancer: a qualitative study. Oncol Nurs Forum 40(6):E393\u2013E402","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"2300_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11\u201348. https:\/\/doi.org\/10.1016\/j.clnu.2016.07.015","journal-title":"Clin Nutr"},{"key":"2300_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.critrevonc.2014.10.014","volume":"94","author":"M Muscaritoli","year":"2015","unstructured":"Muscaritoli M, Molfino A, Lucia S et al (2015) Cachexia: a preventable comorbidity of cancer. a T.A.R.G.E.T approach. Crit Rev Oncol Hematol 94:251\u2013259. https:\/\/doi.org\/10.1016\/j.critrevonc.2014.10.014","journal-title":"Crit Rev Oncol Hematol"},{"key":"2300_CR19","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2147\/CMAR.S261585","volume":"12","author":"J Ni","year":"2020","unstructured":"Ni J, Zhang L (2020) Cancer cachexia: definition, staging, and emerging treatments. Cancer Manag Res 12:5597. https:\/\/doi.org\/10.2147\/CMAR.S261585","journal-title":"Cancer Manag Res"},{"key":"2300_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2018.07.008","volume":"70","author":"W-Q Shen","year":"2018","unstructured":"Shen W-Q, Yao L, Wang X-q et al (2018) Quality assessment of cancer cachexia clinical practice guidelines. Cancer Treat Rev 70:9\u201315. https:\/\/doi.org\/10.1016\/j.ctrv.2018.07.008","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2300_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00520-008-0486-1","volume":"17","author":"D Churm","year":"2009","unstructured":"Churm D, Andrew IM, Holden K et al (2009) A questionnaire study of the approach to the anorexia\u2013cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 17(5):503\u2013507. https:\/\/doi.org\/10.1007\/s00520-008-0486-1","journal-title":"Support Care Cancer"},{"issue":"2","key":"2300_CR22","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"P Porporato","year":"2016","unstructured":"Porporato P (2016) Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5(2):e200\u2013e200. https:\/\/doi.org\/10.1038\/oncsis.2016.3","journal-title":"Oncogenesis"},{"issue":"1","key":"2300_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jcsm.12010","volume":"6","author":"C Cooper","year":"2015","unstructured":"Cooper C, Burden ST, Cheng H et al (2015) Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia Muscle 6(1):99\u2013111. https:\/\/doi.org\/10.1002\/jcsm.12010","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"21","key":"2300_CR24","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.20.00611","volume":"38","author":"EJ Roeland","year":"2020","unstructured":"Roeland EJ, Bohlke K, Baracos VE et al (2020) Management of cancer cachexia: ASCO guideline. J Clin Oncol 38(21):2438\u20132453. https:\/\/doi.org\/10.1200\/JCO.20.00611","journal-title":"J Clin Oncol"},{"issue":"3","key":"2300_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","volume":"8","author":"TS Solheim","year":"2018","unstructured":"Solheim TS, Laird BJ, Balstad TR et al (2018) Cancer cachexia: rationale for the MENAC (Multimodal\u2014Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Support Palliat Care 8(3):258\u2013265. https:\/\/doi.org\/10.1136\/bmjspcare-2017-001440","journal-title":"BMJ Support Palliat Care"},{"issue":"3","key":"2300_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.physio.2015.10.007","volume":"102","author":"CL Granger","year":"2016","unstructured":"Granger CL, Parry SM, Edbrooke L et al (2016) Deterioration in physical activity and function differs according to treatment type in non-small cell lung cancer\u2013future directions for physiotherapy management. Physiotherapy 102(3):256\u2013263. https:\/\/doi.org\/10.1016\/j.physio.2015.10.007","journal-title":"Physiotherapy"},{"issue":"4","key":"2300_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/spc.0000000000000087","volume":"8","author":"J Reid","year":"2014","unstructured":"Reid J (2014) Psychosocial, educational and communicative interventions for patients with cachexia and their family carers. Curr Opin Support Palliat Care 8(4):334\u2013338. https:\/\/doi.org\/10.1097\/spc.0000000000000087","journal-title":"Curr Opin Support Palliat Care"},{"key":"2300_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.02.034","author":"KA Bland","year":"2021","unstructured":"Bland KA, Harrison M, Zopf EM et al (2021) Quality of life and symptom burden improve in patients attending a multidisciplinary clinical service for cancer cachexia: a retrospective observational review. J Pain Symptom Manage. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.02.034","journal-title":"J Pain Symptom Manage"},{"key":"2300_CR29","doi-asserted-by":"publisher","first-page":"110498","DOI":"10.1016\/j.nut.2019.04.009","volume":"70","author":"X-Y Chen","year":"2020","unstructured":"Chen X-Y, Zhang X-Z, Ma B-W et al (2020) A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer. Nutrition 70:110498. https:\/\/doi.org\/10.1016\/j.nut.2019.04.009","journal-title":"Nutrition"},{"issue":"5","key":"2300_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jpainsymman.2016.12.325","volume":"53","author":"T Zhou","year":"2017","unstructured":"Zhou T, Yang K, Thapa S et al (2017) Differences in symptom burden among cancer patients with different stages of cachexia. J Pain Symptom Manage 53(5):919\u2013926. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.12.325","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"2300_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/SPC.0000000000000241","volume":"10","author":"M Maddocks","year":"2016","unstructured":"Maddocks M, Hopkinson J, Conibear J et al (2016) Practical multimodal care for cancer cachexia. Curr Opin Support Palliat Care 10(4):298. https:\/\/doi.org\/10.1097\/SPC.0000000000000241","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"2300_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","volume":"33","author":"L Martin","year":"2015","unstructured":"Martin L, Senesse P, Gioulbasanis I et al (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33(1):90\u201399. https:\/\/doi.org\/10.1200\/JCO.2014.56.1894","journal-title":"J Clin Oncol"},{"issue":"6","key":"2300_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/0269216310373163","volume":"24","author":"M Watson","year":"2010","unstructured":"Watson M, Coulter S, McLoughlin C et al (2010) Attitudes towards weight and weight assessment in oncology patients: survey of hospice staff and patients with advanced cancer. Palliat Med 24(6):623\u2013629. https:\/\/doi.org\/10.1177\/0269216310373163","journal-title":"Palliat Med"},{"key":"2300_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","volume":"99","author":"R Tarricone","year":"2016","unstructured":"Tarricone R, Ricca G, Nyanzi-Wakholi B et al (2016) Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: a systematic review. Crit Rev Oncol Hematol 99:49\u201362. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.12.008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"2300_CR35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/00016489.2016.1277263","volume":"137","author":"H Orell-Kotikangas","year":"2017","unstructured":"Orell-Kotikangas H, \u00d6sterlund P, M\u00e4kitie O et al (2017) Cachexia at diagnosis is associated with poor survival in head and neck cancer patients. Acta Otolaryngol 137(7):778\u2013785. https:\/\/doi.org\/10.1080\/00016489.2016.1277263","journal-title":"Acta Otolaryngol"},{"issue":"8","key":"2300_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1177\/0269216309106980","volume":"23","author":"IM Andrew","year":"2009","unstructured":"Andrew IM, Waterfield K, Hildreth AJ et al (2009) Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome. Palliat Med 23(8):680\u2013688. https:\/\/doi.org\/10.1177\/0269216309106980","journal-title":"Palliat Med"},{"issue":"6","key":"2300_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jpainsymman.2012.06.013","volume":"45","author":"W Rhondali","year":"2013","unstructured":"Rhondali W, Chisholm GB, Daneshmand M et al (2013) Association between body image dissatisfaction and weight loss among patients with advanced cancer and their caregivers: a preliminary report. J Pain Symptom Manage 45(6):1039\u20131049. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.06.013","journal-title":"J Pain Symptom Manage"},{"key":"2300_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/ecc.12032","volume":"22","author":"C Millar","year":"2013","unstructured":"Millar C, Reid J, Porter S (2013) Refractory cachexia and truth-telling about terminal prognosis: a qualitative study. Eur J Cancer Care 22:326\u2013333. https:\/\/doi.org\/10.1111\/ecc.12032","journal-title":"Eur J Cancer Care"},{"issue":"4","key":"2300_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","volume":"7","author":"T Aoyagi","year":"2015","unstructured":"Aoyagi T, Terracina KP, Raza A et al (2015) Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 7(4):17. https:\/\/doi.org\/10.4251\/wjgo.v7.i4.17","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"2300_CR40","doi-asserted-by":"publisher","first-page":"188359","DOI":"10.1016\/j.bbcan.2020.188359","volume":"1873","author":"JA Siddiqui","year":"2020","unstructured":"Siddiqui JA, Pothuraju R, Jain M et al (2020) Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta (BBA) Rev Cancer 1873(2):188359. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188359","journal-title":"Biochim Biophys Acta (BBA) Rev Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02300-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:48:29Z","timestamp":1680536909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02300-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2300"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02300-6","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DCC is an unpaid member of an advisory board for Helsinn Pharmaceuticals and has consulted to Mayne Pharma and received intellectual property payments from them. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}